Sign in

CIK 0001137883

  • Non-accelerated filer
  • Smaller reporting company

BRAINSTORM CELL THERAPEUTICS INC.

Sign in to watch
Ticker
BCLI
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
207273918
Phone
+1 201-488-0460
Business address
1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
Former names
BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2011-01-23 ACCBT Corp. 10% owner Exercise or conversion · Right to Acquire Warrant to Purchase Common Stock −4,537,500 0
2011-01-23 ACCBT Corp. 10% owner Exercise or conversion · Right to Acquire Common Stock −10,499,999 0
2010-12-16 SHORR ROBERT G L Director Grant or award +200,000 300,000
2010-12-16 ARBEL IRIT Director Grant or award · Stock Option (right to buy) +200,000 200,000
2010-12-16 TAUB MALCOLM S Director Grant or award · Stock Option (right to buy) +200,000 200,000
2010-12-16 Israeli Avi Director Grant or award · Stock Option (right to buy) +200,000 200,000
2010-06-23 Sossover Liat Chief Financial Officer Grant or award · Stock Option (right to buy) +400,000 400,000
2010-05-06 TAUB MALCOLM S Director Grant or award +100,000 100,000
2010-04-13 Israeli Avi Director Grant or award · Stock Option (right to buy) +166,666 166,666
2010-02-24 ACCBT Corp. 10% owner Exercise or conversion · Right to Acquire Common Stock −2,000,001 10,499,999
2010-02-22 STOLICK DAVID Chief Financial Officer Sale −100,000 $0.36 $36K 150,000
2010-02-17 STOLICK DAVID Chief Financial Officer Sale −2,000 $0.36 $720 250,000
2010-02-16 STOLICK DAVID Chief Financial Officer Sale −3,000 $0.36 $1K 392,000
2010-02-16 STOLICK DAVID Chief Financial Officer Sale −140,000 $0.36 $50K 252,000
2010-02-12 STOLICK DAVID Chief Financial Officer Sale −5,000 $0.36 $2K 395,000
2010-02-12 STOLICK DAVID Chief Financial Officer Exercise or conversion · Stock Option (right to buy) +400,000 0
2009-12-13 ARBEL IRIT Director Grant or award · Stock Option (right to buy) +100,000 100,000
2009-10-28 ACCBT Corp. 10% owner Exercise or conversion · Right to Acquire Common Stock −9,916,667 12,500,000
2009-10-26 SHORR ROBERT G L Director Sale −40,000 $0.31 $12K 100,000
2009-10-22 SHORR ROBERT G L Director Sale −10,000 $0.37 $4K 140,000

Page 16 of 22 · 426 trades